STAAR Surgical Assets & Liabilities Overview 2010-2023 | STAA
STAAR Surgical assets & liabilities overview from 2010 to 2023. Assets & liabilities overview can be defined as overview of the balance sheet showing the primary categories of assets, liabilities and equity in a single chart.
| STAAR Surgical Annual Assets & Liabilities Overview (Millions of US $) |
|---|
| STAAR Surgical Quarterly Assets & Liabilities Overview (Millions of US $) |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $2.307B | $0.322B |
| Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $71.394B | 19.11 |
| Becton Dickinson (BDX) | United States | $66.895B | 19.43 |
| West Pharmaceutical Services (WST) | United States | $26.385B | 47.05 |
| Cardinal Health (CAH) | United States | $25.104B | 15.09 |
| Align Technology (ALGN) | United States | $23.254B | 44.92 |
| Cooper (COO) | United States | $17.657B | 26.72 |
| Labcorp (LH) | United States | $16.691B | 14.40 |
| Henry Schein (HSIC) | United States | $9.396B | 16.25 |
| DENTSPLY SIRONA (XRAY) | United States | $6.339B | 16.70 |
| Merit Medical Systems (MMSI) | United States | $4.284B | 24.51 |
| Patterson (PDCO) | United States | $2.309B | 11.06 |
| CONMED (CNMD) | United States | $2.025B | 18.37 |
| Atrion (ATRI) | United States | $0.695B | 35.81 |
| Lifevantage (LFVN) | United States | $0.080B | 12.89 |
| Pro-Dex (PDEX) | United States | $0.066B | 24.91 |
| Biolase (BIOL) | United States | $0.005B | 0.00 |